MRVT Miravant Med Tech: Infinity and Beyond? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MRVT Miravant Med Tech: Infinity and Beyond?

MRVT 0.00

Jun 16 4:00 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arcane Lore who wrote (31)	7/19/1998 6:56:00 PM
From: GoletaDan	Read Replies (1) of 67

When taken along with QLTIF's targeting of the wet macular degeneration application for their PDT drug, the rebuttal of Miravant's market estimate by The Macular Degeneration Foundation effectively reduces the potential market by a factor of 30. Applying this to the share price would give a current price of less than a buck. About right.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next